Actos (Pioglitazone) Lowers MI Risk by 19%

Clip courtesy of http://www.medstores.net

Actos (Pioglitazone) Lowers Myocardial infarction (Heart attack) Risk by 19%

Actos (Pioglitazone) is a prescription drug of the class thiazolidinedione (TZD) with hypoglycemic (antihyperglycemic, antidiabetic) action. Pioglitazone is marketed as trademarks Actos in the USA and UK, Glustin in Europe,"Glizone" and "Pioz" in India by Zydus CND and USV respectively and Zactos in Mexico by Takeda Pharmaceuticals. Actos was the tenth-best selling drug in the U.S. in 2008, with sales exceeding $2.4 billion.

Actos (Pioglitazone) is used for the treatment of diabetes mellitus type 2 (previously known as non-insulin-dependent diabetes mellitus, NIDDM) in monotherapy and in combination with a sulfonylurea, metformin, or insulin. Pioglitazone has also been used to treat non-alcoholic steatohepatitis (fatty liver), but this use is presently considered experimental

Category:

Science & Technology

Tags:

• Generic
• Actos
• Pioglitazone
• prescription
• drug
• diabetes
• mellitus
• type
• Lowers
• Myocardial
• infarction
• Heart
• attack